Results for safety pharmacology translation from English to Maltese

safety pharmacology
farmakoloġija ta' sikurezza

animal toxicology and safety pharmacology
tossikoloġija u s-sigurtà farmakoloġika fl-annimali

pharmaco-dynamics (including safety pharmacology)
farmako-dinamiċi (inkluż il-farmakoloġija tas-sikurezza)

rimonabant was found in one of two safety pharmacology studies.
iż- żieda fl- inċidenza u/ jew is- severità tas- sinjali kliniċi suġġestivi ta ’ żieda ta ’ iperestesja tal- ħass

for preclinical cardiovascular safety pharmacology studies, see section 5.3.
għal studji prekliniċi kardjovaskulari ta’ sigurtà farmakoloġika, ara sezzjoni 5.3.

non-clinical safety pharmacology studies reveal no special hazard for humans.
studji mhux kliniċi ta’ sigurtà farmakoloġika ma juru l-ebda periklu speċjali għall-bnedmin.

a proconvulsant activity of rimonabant was found in one of two safety pharmacology studies.
attività ta’ rimonabant li wasslet għall-aċcessjoni instabet f’wieħed minn żewġ studji dwar is-sigurtà farmakoloġika.

conventional safety pharmacology studies revealed no special hazards at clinically relevant doses.
studji konvenzjonali ta’ sigurtà farmakoloġika ma wrew l-ebda perikli b’dożi klinikament rilevanti.

emesis has been observed in both the safety pharmacology and the repeated-dose toxicity studies.
rimettar ġie osservat kemm fil-farmakoloġija tas-sigurta’ u kemm fi studji fuq tossiċita’ wara dożi ripetuti.

standard safety pharmacology experiments were performed under light protection in the mouse, rat and dog.
esperimenti standard ta’ sigurtà farmakoloġika ġew imwettqa taħt protezzjoni mid-dawl fil-ġurdien, il-far u l-kelb.

non-clinical safety pharmacology studies on tenofovir disoproxil reveal no special hazard for humans.
studji mhux kliniċi ta’ sigurtà farmakoloġika fuq tenofovir disoproxil ma juru l-ebda periklu speċjali għall-bnedmin.

non-clinical data reveal no special risk for humans based on safety pharmacology and toxicity studies.
informazzjoni li mhix klinika, ibbażata fuq studji dwar il-farmakoloġija tas-sigurtà u tat-tossiċità, ma turi l-ebda riskju speċjali għall- bnedmin.

safety pharmacology studies did not reveal any adverse effects on central nervous, respiratory or cardiovascular function.
studji dwar is-sigurtà farmakoloġika ma wrew l-ebda effetti avversi fuq is-sistema nervuża ċentrali, respiratorja jew funzjoni kardjovaskulari.

conventional studies of safety pharmacology, genotoxicity or carcinogenic potential did not reveal a special hazard for humans.
studji konvenzjonali tal-farmakoloġija tas-sigurtà, ġenotossiċità jew potenzjal karċinoġeniku ma kixfux periklu speċjali għan-nies.

this was based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenicity, and fertility.
dan kien bażat fuq studji konvenzjonali ta’ sigurta` farmakoloġika, tossiċita` minn dożi ripetuti, ġenotossiċita`, karċinoġeneċita`, u fertilita`.

non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology and genotoxicity.
tagħrif ta’ qabel l-użu kliniku magħmul fuq studji konvenzjonali ta’ sigurtà farmakoloġika u effett tossiku fuq il-ġeni, ma juru l-ebda periklu speċjali għall-bnedmin.

non-clinical data reveal no special hazard for humans based on evaluations of safety pharmacology, and repeated dose toxicity.
tagħrif mhux kliniku bbażat fuq valutazzjonijiet ta’ sigurtà farmakoloġika, u effett tossiku minn dożi ripetuti ma juri l-ebda periklu speċjali għall-bnedmin.

this finding is based on conventional safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenicity, and reproduction toxicity studies.
din is-sejba hija bbażata fuq studji konvenzjonali ta’ sigurtà farmakoloġika, effett tossiku minn dożi ripetuti, effett tossiku fuq il-ġeni, riskju ta’ kanċer u effett tossiku fuq is-sistema riproduttiva.

iclusig has been evaluated in safety pharmacology, repeat-dose toxicity, genotoxicity, reproductive toxicity, phototoxicity and carcinogenicity studies.
iclusig ġie evalwat fi studji ta’ sigurtà farmakoloġika, tossiċità dovuta għal dożi ripetuti, ġenotossiċità tossiċità riproduttiva, studji ta’ fototossiċità u karċinoġeniċità.

safety pharmacology: cloned human cardiac potassium channel (herg) trafficking in vitro was inhibited by 75% at 30μm of saquinavir.
sigurtà farmakoloġika: waqt studji in vitro, l-ittraffikar fil-kanali kardijaċi tal-potassium umani (herg) ikklonati kien impedut b’75% f’konċentrazzjoni ta’ 30μm ta’ saquinavir.